chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had a severe shaking experience.  It lasted about 5 minutes.  Not a seizure but very similar.  Patient was aware during the experience. very disoriented afterwards. Patient said she had tingling in her head. which lasted about 1-2 hours.
Patient woke up with 102 temp, and nauseated at 4am on 8/16/17. I spoke with pts mother on 8/16 at about 5pm, he was still having all the same sx, but also included body aches, and headache, fatigue. I called his mother on 8/17/17 at 8:20 am, she stated that his temp broke, and he was starting to feel better.
I received my vaccine around 430pm Friday December 10, when i woke up the next day my whole body hurt. My back, elbow, neck, knees etc. Most significantly my skin hurt. It hurt to even be touched. This did happen after my second shot as well, but my skin felt like it was on fire and any contact hurt. I'm still pretty sore waking up on the 12th but not as bad as yesterday.
p/inject pt cried p/quieted, pt repositioned for next inject; pt became limp then 2 generalized jerking motions of arms & legs followed by limpness & pale-initial p160, unable to hear BP11:03; BP 60/30, P160; 1104 BP 70/50, P100;
Severe headache, fever, chills, extreme fatigue, weakness, loss of appetite, body aches, and pain in arm at and around injection. As a high level endurance athlete, I was unable to get out of bed for 24 hours. Symptoms improved gradually after that. Minor headache continued through 48 hours. Inability to fully exert myself has continued through day 4, although gradually improving each day.
After Vaccine, child turned red and had welps over entire body and was crying. She also started to sweat, no fever. TYLENOL given, child was able to be consoled and ate and fell asleep, we kept in office for 60 minutes following reaction for observation. Welps and redness went away.
Information has been received from a physician concerning a 64 year old male with high cholesterol and no drug reactions or allergies who on 29-SEP-2010 was vaccinated SC with PNEUMOVAX 23 at the left deltoid. Concomitant therapy included simvastatin (manufacturer unspecified). The next day on 30-SEP-2010 (also reported on 29-SEP-2010) the patient's left deltoid (the site of administration) swelled to twice its normal size with erythema, edema and tenderness. The patient presented to the physician the following day, 2 days after the shot. The physician prescribed 50mg of BENADRYL 3 times a day and AUGMENTIN 500mg 3 times a day for 3 days. No lab/diagnostics studios were performed. Therapy was reported as continued. As of 04-OCT-2010, the symptoms had almost completely resolved. Additional information has been requested.
Patient had redness, tenderness, and swelling at the Pneumovax injection site. Patient went to PCP and the doctor's office sent her to the ER. ER physician diagnosed patient with a skin infection due to the vaccination. Patient was not allergic to the vaccine.
severe back muscle spasms; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MUSCLE SPASMS (non-serious), outcome "unknown", described as "severe back muscle spasms". Additional information: Patient had severe back muscle spasms post dose 1. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe thirst, stomach pain, severe headaches, dizziness, lightheadedness, fatigue, sleepiness.
Information has been received from a pharmacist refers to a 71 years old female patient. The patient's medical history included chickenpox when was a child, chad carcinoma insitu left breast (June 2008) and chat bilateral mastectomy. On 23-FEB-2012, the patient was vaccinated with ZOSTAVAX (lot # 672476/1605AA), 1 ml, right deltoid, subcutaneously. No other co-suspects were reported. No concomitant medications were reported. The patient did not presented illness at the time of vaccination. The patient was not exposure to chickenpox or herpes zoster. It was noted that the patient did not experienced a rash at the injection site or elsewhere within 42 days of the vaccination. On 04-DEC-2012 in the afternoon, the patient experienced herpes zoster. Blisters started on 16-DEC-2012, and had pain that kept when awake. The patient was seen in the office on 17-DEC-2012 and had stated to breakout with pain along bra line from midline center front to mid line back on the left, 6 cm at greatest, lesions to numerous to count and was diagnosed with herpes zoster the same day. Tried to obtain some fluids but blisters were too small. The pain was level 8 (from 1 to 10). No treatment information was reported. The patient required medical attention. The patient was not performed fluorescent antibody test. Was unable to collected specimen for PCR test. Photo was not taken. At the time of the report, the outcome of herpes zoster was unknown. The relatedness for herpes zoster was unknown for ZOSTAVAX. Additional information has been requested.
The left side of my face went numb, and stayed numb for over 24 hours before the numb sensation went away on its own.  It felt like someone was holding an ice pack up against the left side of my face.
4 days after the vaccine was administered the patient reported to the vaccine site.  She reports and shows approximately 20 areas of bruising on multiple parts of her body.  All are isolated to her extremities and she reports no pain associated.  I completed this for her as we had an interpreter and the ability to do so in a timely manner.  She has been instructed on how to access the VAER's system for further reporting.
Pt recvd 3 doses of Hep B vax on 1AUG89, 29AUG89 & 23JAN90 following these titer was neg; pt given 4thh dose of vax on 8AUG90 following 4th dose titer was neg;
Mistakenly assumed patient was immunosuppressed because pt insisted doctor wanted her immunized immediately, after telling pt it was too early for routine booster shot.  So patient got shot at less than 6 months and got full 0.5ml dose.  The patient called our corporate office to complain of various side effects, unknown to me, and spoke to our Regional Pharmacy Leader.
Generalized muscle weakness/motor weakness. Admitted to hospital and diagnosed with Guillain Barre Syndrome. Given IVIG and Neurontin.  7/18/08 MR received for DOS 6/20-23/2008 with D/C DX:  Guillain-Barre Syndrome. Pt presented with 2 week hx of muscle pain, shaking movements, and difficulty walking. Pt had 1 day of fever and diarrhea which occurred 4 days after Hep A vax, 1 week prior to onset of current sx. 3 lb wt loss with decreased energy and appetitite.  PE (+) for irritability, decreased strength and decreased/absent reflexes. Bilateral dysdiadochokinesia noted. Tx with IVIG with improvement noted.
Red Swollen Rash on 90% of left upper arm, hot to touch ,swollen bump at site of injection,headache, flu like symptoms. rash started within 24 hours of administration. rash still same size on Wednesday (10/2/19) as on Sunday( 09/29/19) per patients statement.
Unable to move the left side of his mouth; Unable to close his eyes tightly; The muscle of the left side of his face is not as strong as the muscle of the right side of his face; The left side of his face is numb /It is like he received a Lidocaine shot; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face), HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot) and HEADACHE (Headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0211321A) for COVID-19 vaccination.     Concurrent medical conditions included Headache (He was having headaches on and off before receiving the vaccine.).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced HEADACHE (Headache). On 12-Apr-2021, the patient experienced HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face) and HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot). At the time of the report, HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face), HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included paracetamol for headache.
seven days after administration the vaccine injection site started itching and developed a raised, erythematous quality to it. It expanded from 1 to 3 inches within 24 hours and subsided over several days. No systemic findings. treated with benadryl orally and topical allergy cream.
Patient received vaccine & had syncope - fell to floor & started twitching, lasted about 10 seconds. 911 was called.
achy/sore,; don't feel like getting out of; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st July 2020, the patient received Shingrix. In July 2020, less than a week after receiving Shingrix, the patient experienced pain and malaise. On an unknown date, the outcome of the pain was not recovered/not resolved and the outcome of the malaise was unknown.   It was unknown if the reporter considered the pain and malaise to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received Shingrix vaccine and had achy, sore, and don't felt like getting out of bed. The patient asked how long would it last.
Itchy red rash (papular) appeared over chest the evening after vaccination, followed by the appearance of similar lesions across both cheeks and ?R posterior upper arm the next morning.  Symptoms persisted for 4-5days prompting patient to come to clinic  for in-person evaluation via drop-in clinic on 1/22/2021
left side of his face went numb. / numbness started above his left ear and migrated down the neck to his shoulder blade; felt like burning when hand was rubbed over the left side of his neck; felt also like water trickling down his neck; Shingrix triggered something in the nerve of the neck; This case was reported by a consumer via call center representative and described the occurrence of numbness in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in February 2020).   In July 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix and an unknown time after starting Valacyclovir, the patient experienced numbness, burning sensation, neck discomfort and neurological disorder nos. The patient was treated with gabapentin and valaciclovir hydrochloride (Valacyclovir). On an unknown date, the outcome of the numbness was not recovered/not resolved and the outcome of the burning sensation, neck discomfort and neurological disorder nos were unknown.   It was unknown if the reporter considered the numbness, burning sensation, neck discomfort and neurological disorder nos to be related to Shingrix.  Additional details were provided as follows: The patient received 2nd dose of Shingrix in the left arm.  The patient reported the left side of his face went numb. The numbness started above his left ear and migrated down the neck to his shoulder blade. It felt like burning when hand was rubbed over the left side of his neck, it felt also like water trickling down his neck. The patient's family physician thought the patient had a stroke and had him go to the emergency room. A neurologist determined getting Shingrix triggered something in the nerve of the neck. The patient was treated with Gabapentin and (possibly) Valacyclovir, the numbness went away but now it was coming back. The reporter did not consent to follow up.
Client fainted and was found laying outside in the parking area. When I was called he was already sitting inside his car. He looked sluggish and pale. A couple of ladies helped him walk to his car. Oxygen via mask was applied and BP was 80/40. Client was talking, pulse was regular at 60 bpm but client was breathing a litte fast. Ambulance arrived shortly and they took over. Client declined to go to hospital. He felt better and his color was back. Mother drove him home.
Immediatenot adverse symptomswere soreness, redness, swelling at injection site; the following day, had fatigue, flu-like aches all over. These adverse symptoms appeared in the morning of April 9, 2018. There were two blisters on the left side of my chest just below the nipple, and one on my back over the left shoulder blade. There was soreness along the left pectorals. Following day, there was more soreness and extreme sensitivity and pain on the blisters when in contact with clothing. The following day, April 11, the pain increased. That night the pain was 8 out of 10 in bursts for 4 hours. Today, April 12, started acyclovir, 800mg 5/day and Ibuprofen, 2/6 hours. The pain is reduced, the three blisters remain.
SEVERE PAIN IN ARM & NECK FOLLOWED BY BODY ACHES, CHILLS, FEVER AND FATIGUE.
Burning and swelling at injection site.  Localized reaction-erythema and swelling measuring 10 cm x 5 cm.  No ecchymosis.  Prescribed: Atarax 25mg94hr as occasion requires.
Information has been received from an investigator concerning a 77 year old male with chronic obstructive pulmonary disease, Alzheimer's dementia, hypertension, congestive heart failure, peripheral vascular disease, hyperlipidaemia, glaucoma, gastrooesophageal reflux disease, shingles, chronic renal insufficiency and cigarette addiction and previous surgeries of appendicectomy, total hip arthroplasty, cataract surgery, bowel obstruction and right endarterectomy in July 1995 who on 18-JUN-2008 was vaccinated with ZOSTAVAX (Oka/Merck) (lot # 656412/1476F). This report was part of a study. The patient was hospitalized in May of 2008. On 12-JUN-2008, he was referred for Hospice care. On 10-JUL2008, he as admitted to a skilled nursing facility for Hospice care and died 34 days after vaccination, on 22-JUL-2008. The cause of death was COPD, HTN, PVD and CHF. A lot check has been requested. This is one of several reports received from the same source. Additional information has been requested. 1/9/09-death certificate received- COD-cardiopulmonary arrest. chronic obstructive pulmonary disease.
Post vax, the pt developed swelling and erythema with subsequent cellulitis on upper left thigh. Treated with Kelfex.
Spots on my face, red spots and they continue to get larger and larger; Both side of my face is fiery red and my chin is very rough, its not red but it is very rough; chin is very rough; spots on my face; My arm was sore; Arm was swollen and hard; It was swollen and very firm and I also had a bruise there; My arm was sore; Arm was swollen and hard; It was swollen and very firm and I also had a bruise there; My arm was sore; Arm was swollen and hard; It was swollen and very firm and I also had a bruise there; This is a spontaneous report received from a contactable nurse.  A 87-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0169), dose 1 via an unspecified route of administration, administered in Arm Left on 19Apr2021 (At the age of 87 years) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation.  Medical history included atrial fibrillation, osteoarthritis, myocardial infarction, three heart attacks and walking aid user from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 19Apr2021, the patient experienced swollen arm and it was hard and very firm. On 20Apr2021, there was bruise on the swollen arm and there spots on the face, red spots and they continue to get larger and larger. On 22Apr2021, both side of the face was fiery red, and chin was very rough. Patient called the family doctor and she ordered Benadryl tablet (treatment) for me and she said before I get the second injection to take one of those before I get the injection. So, I just want you to know about the reaction I had."At the time of reporting the outcome of the events were  unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report was received from a nurse via a field employee and refers to a male patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On unknown dates, the patient was vaccinated with GARDASIL 9 dose 1 and dose 2 (exact dose, route of administration, anatomical location, lot numbers and expiration dates were not provided) for prevention of human papilloma virus (HPV). On unspecified dates, the patient experienced a rash after his first dose of GARDASIL 9 and had to go to the hospital after the second dose. The outcome of the events was unknown. The relatedness between the events and GARDASIL 9 was not provided. Additional information has been requested.
p/vax pt broke out in an itchy rash on hands, arms, back & legs;tx by PMD w/atarax;upon exam on 7/22/99 had papular rash;
1/17/22 pt admitted to Hospital; found to be positive for COVID; pt having SOB; refused dialysis; does want to be treated for dyspnea; on continuous O2 supplementation; poor oral intake; requested hospice care; 1/18/22 admitted to Hospice with ESRD; pt passed away at the facility.
feeling very tired; aches and pains all over; Headache; Chills; fever; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (received 1st dose on an unknown date. For the tolerance of 1st dose, refer linked case US2021AMR092233).   On 22nd April 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In April 2021, 12 hrs after receiving Shingrix, the patient experienced tiredness, general body pain, headache, chills and fever. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the tiredness, general body pain, headache, chills and fever were not recovered/not resolved.   The reporter considered the tiredness, general body pain, headache, chills and fever to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's wife.   The patient received 2nd dose of Shingrix in left deltoid. On 23rd April 2022, about 3 in the morning, the patient began to experience very tired, aches and pains all over, headache, chills and fever.  Till the time of reporting, the symptoms were ongoing and had not resolved. The reporter consented to follow up. No further information was reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR092233:1st dose
This is a spontaneous report from a contactable nurse communicated to a Pfizer sales representative. This nurse reported similar events for 4 patients. This is the third of four reports. A patient of unspecified age ethnicity and gender received PREVNAR 13 (NDC 0005-1971-01, LOT S43277), via an unspecified route of administration on an unspecified date at 0.5 ml, single for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced shot is hurting and stinging, redness, swelling & hard knot at injection site lasting several days, adminstering product with possible quality issue and vaccine seems a lot thicker than normal all on an unspecified date with outcome of unknown. Nursesstated with the most recent lot number of PREVNAR 13 that patients had been complaining about the shot hurting and stinging. They also stated the vaccine seemed a lot thicker than normal. Four patients have called into the office about redness, swelling and a hard knot at the injection site lasting for several days. there were also bumps and immunization stinging. Sales representative stated onset was within the last 2 weeks with the most recent lot number.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2017400561 similar report from same reporter.
feel somewhat dizzy; slight chest cramp; slightly short of breathe; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (feel somewhat dizzy), CHEST PAIN (slight chest cramp) and DYSPNOEA (slightly short of breathe) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced DIZZINESS (feel somewhat dizzy), CHEST PAIN (slight chest cramp) and DYSPNOEA (slightly short of breathe). At the time of the report, DIZZINESS (feel somewhat dizzy), CHEST PAIN (slight chest cramp) and DYSPNOEA (slightly short of breathe) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.  The patient had first vaccine Friday. On Thursday, The patient felt somewhat dizzy, slight chest cramp and slightly short of breathe.   Reporter did not allow further contact
I had a shingle shot. 1 I had a rash on my waist in a cluster. 2 Spots all over my body. 3 Hair loss. 4 Itching. 5 It lasted for at least a month.
RN was notified by coroner's office that pt died of SIDS 29APR93;
Arm became black and blue. Extremely achy for 5 days. Can't break a fever of 99. Pt believes the vaccine caused her to get bronchitis, which she was diagnosed with a week after getting the vaccine.
Pt recv vax on 3/18/99; on 3/20/99 pt exp  knee & ankle pain (left&right); tx=Naprelan